Foundation for the Accreditation of Cellular Therapy

Analysis

Foundation for the Accreditation of Cellular Therapy is a registered charity in United States, based in Omaha, NE. It received its IRS tax-exemption ruling in March 1997, 29 years ago. Its declared purposes cover medical research, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Foundation for the Accreditation of Cellular Therapy reported income of $5.5m and spending of $5.0m, spending 91% of its income. Across the 5 years on record, from December 2019 to December 2023, income grew from $3.3m to $5.5m (+65%), an average of +13% a year. The sharpest change came in the year to December 2022, when income rose by 32%. Over the whole period it spent 89% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Foundation for the Accreditation of Cellular Therapy sits at the 80th percentile: it is larger than about 80% of them. Against every charity in United States with reported income it ranks in the 92nd percentile, and in the 92nd percentile within NE. Charities of a similar size with the same main cause include Medical Review of North Carolina Inc ($5.5m), Mason City Area Nursing Home Association Inc ($5.5m) and Usc Arcadia Hospital Foundation ($5.5m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 0.5% and program service revenue 99% of the total. At year end it held assets of $2.9m against liabilities of $0, net assets of $2.9m. It reported 32 employees.